Bristol-Myers Squibb Co

'This is the mental health moment': Innovation and M&A are helping to boost these stocks to new heights
Health

'This is the mental health moment': Innovation and M&A are helping to boost these stocks to new heights

There’s been a lot of chatter about the mental health crisis since the Covid-19 pandemic. Overall, 12 mental health disorders affect 970 million people around the world — or one in eight people, according to the Institute for Health Metrics and Evaluation’s Global Burden of Disease. That can mean anything from anxiety and depression to […]

Read More
Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
Health

Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations

Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty Images A federal judge on Monday tossed a lawsuit brought by a major pharmaceutical industry lobbying group and two other organizations, which challenged […]

Read More
Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
Health

Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing

Sen. Bernie Sanders, left, appears at a news conference with Sen. Ed Markey on issuing subpoenas for pharmaceutical company CEOs to testify regarding drug prices, in the Capitol, Jan. 25, 2024. Bill Clark | Cq-roll Call, Inc. | Getty Images Senators will question the CEOs of Johnson & Johnson, Merck and Bristol Myers Squibb on […]

Read More
Fourth-quarter earnings are shaping up to be the best of 2023, but there's a catch
Health

Fourth-quarter earnings are shaping up to be the best of 2023, but there's a catch

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., February 1, 2024.  Brendan McDermid | Reuters Here’s how big of a surprise corporate profits have been this earnings season: the fourth-quarter is now shaping up to be the best of 2023. Despite ongoing macroeconomic concerns that have […]

Read More
Shares producing the most significant moves midday: Meta, Apple, Intel, Amazon, Clorox and additional
World

Shares producing the most significant moves midday: Meta, Apple, Intel, Amazon, Clorox and additional

Look at out the companies making headlines in midday trading. Meta Platforms — The Fb and Instagram dad or mum soared 20% right after reporting a threefold rise in fourth-quarter income and declaring its 1st dividend, to be paid out in late March. Profits jumped 25% from a year previously, the swiftest fee of growth […]

Read More
Here are Jim Cramer’s rapid-fire takeaways on 6 stocks in the news Friday
Health

Here are Jim Cramer’s rapid-fire takeaways on 6 stocks in the news Friday

Clorox – The consumer products giant saw a huge earnings beat. It’s also rebounding from last year’s cyberattack. “Things are back online, and there’s tremendous demand for their product,” Jim said Friday’s Morning Meeting rapid fire. Tesla – The EV leader issued a recall for 2.2 million cars over a warning light issue. Remember, our […]

Read More
Bristol Myers Squibb results top estimates as new drugs post strong sales growth 
Health

Bristol Myers Squibb results top estimates as new drugs post strong sales growth 

Bristol Myers Squibb reported quarterly earnings and revenue that topped expectations on Friday as its portfolio of new drugs posted strong sales growth.  Here’s what the company reported for the fourth quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG, formerly known as Refinitiv: Earnings per share: $1.70 […]

Read More
S&P 500 futures achieve right after Meta, Amazon success as careers report looms: Dwell updates
World

S&P 500 futures achieve right after Meta, Amazon success as careers report looms: Dwell updates

Traders operate on the ground at the New York Inventory Trade on Feb. 1, 2024. Brendan Mcdermid | Reuters S&P 500 futures rose on Thursday night time as a trio of megacap tech titans reported effects and traders looked forward to the January employment report. Futures tied to the broader marketplace index rose about .6%, […]

Read More
Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat
Health

Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat

Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com.  Three names in the industry – Johnson & Johnson, Merck and Bristol Myers Squibb – face a pivotal few weeks […]

Read More
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Health

Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium.  NYSE Big pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a looming threat that will put tens of billions of dollars in sales at risk between now and 2030, as blockbuster drugs will tumble off a […]

Read More